Literature DB >> 16154306

The limitations and validities of senescence associated-beta-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells.

Nae-Cherng Yang1, Miao-Lin Hu.   

Abstract

The senescence associated-beta-galactosidase (SA-betaG) assay has become one of the most commonly used markers of cell-aging. However, the reliability of the assay is questionable because the enzyme is a non-specific marker for cell-aging. In this study, we found that the SA-betaG activity increased with cell age as well as in confluent quiescent cells or cells under serum starvation, and in cells treated with H2O2. Importantly, we found that SA-betaG activity was irreversibly increased in the senescent cells or H2O2-teated cells, but was reversible in quiescent cells induced by serum starvation or confluence. Using fluorescein di-beta-d-galactopyranoside (FDG) method for SA-betaG detection, we showed that senescent human foreskin fibroblast Hs68 cells did not express a specific enzyme that has a maximal activity at pH 6.0. In the pH profile of the cellular betaG activity in senescent Hs68 cells, only a single peak was found (with maximum at pH 4.6), and no addition peak was found at or around pH 6.0 that could be attributed to the SA-betaG activity. These results support the contention that SA-betaG is the lysosomal betaG that is detectable at suboptimal pH (i.e. pH 6.0) and demonstrate that cell-aging is not the only factor that can increase SA-betaG activity, rendering SA-betaG activity unspecific for cell-aging. Thus, the assay for cell-aging is only reliable when these confounding factors are controlled or excluded.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154306     DOI: 10.1016/j.exger.2005.07.011

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  66 in total

Review 1.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

2.  Accumulation of senescent cells in mitotic tissue of aging primates.

Authors:  Jessie C Jeyapalan; Mark Ferreira; John M Sedivy; Utz Herbig
Journal:  Mech Ageing Dev       Date:  2006-11-20       Impact factor: 5.432

Review 3.  A comparative analysis of the cell biology of senescence and aging.

Authors:  Eun Seong Hwang; Gyesoon Yoon; Hyun Tae Kang
Journal:  Cell Mol Life Sci       Date:  2009-05-07       Impact factor: 9.261

4.  Status of mTOR activity may phenotypically differentiate senescence and quiescence.

Authors:  Sohee Cho; Eun Seong Hwang
Journal:  Mol Cells       Date:  2012-05-07       Impact factor: 5.034

5.  Cultured porcine trabecular meshwork cells display altered lysosomal function when subjected to chronic oxidative stress.

Authors:  Paloma B Liton; Yizhi Lin; Coralia Luna; Guorong Li; Pedro Gonzalez; David L Epstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-09       Impact factor: 4.799

Review 6.  Oncogene-induced senescence and its role in tumor suppression.

Authors:  Jay P Reddy; Yi Li
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-06-18       Impact factor: 2.673

Review 7.  Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Authors:  Robert J Pignolo; Rebekah M Samsonraj; Susan F Law; Haitao Wang; Abhishek Chandra
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

Review 8.  Cellular senescence in renal ageing and disease.

Authors:  Ines Sturmlechner; Matej Durik; Cynthia J Sieben; Darren J Baker; Jan M van Deursen
Journal:  Nat Rev Nephrol       Date:  2016-12-28       Impact factor: 28.314

9.  Autophagic dysregulation in glaucomatous trabecular meshwork cells.

Authors:  Kristine Porter; Joshua Hirt; W Daniel Stamer; Paloma B Liton
Journal:  Biochim Biophys Acta       Date:  2014-12-04

10.  Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.

Authors:  Emilija Manojlovic-Gacic; Milica Skender-Gazibara; Vera Popovic; Ivan Soldatovic; Novica Boricic; Savo Raicevic; Sandra Pekic; Mirjana Doknic; Dragana Miljic; Irina Alafuzoff; Fredrik Pontén; Olivera Casar-Borota
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.